October 20, 2025
1 min read

Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay

The investment is part of the New Jersey company’s plan to spend more than $70 billion on manufacturing, R&D and capital projects in the U.S. starting this year.

Leave a Reply

Your email address will not be published.

Previous Story

Head of addiction medicine society warns of treatment cuts and rising threat of gambling

Next Story

Can better regulation solve surrogacy’s ethical challenges?

Previous Story

Head of addiction medicine society warns of treatment cuts and rising threat of gambling

Next Story

Can better regulation solve surrogacy’s ethical challenges?

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop